[Construction of NF-kappaB siRNA expression vector]

Area of Science:

• Molecular Biology
• Gene Silencing

Background:

• Nuclear factor kappa B (NF-kappaB) plays a crucial role in inflammatory and immune responses.
• Targeting NF-kappaB is a potential therapeutic strategy for various diseases.

Purpose of the Study:

• To develop and characterize a small interfering RNA (siRNA) expression vector targeting NF-kappaB.
• To evaluate the efficacy of this vector in specifically silencing NF-kappaB protein expression.

Main Methods:

• Construction of pcDNA3.1/CT-GFP-TOPO and pSilencer 1.0-U6-siRNA-NF-kappaB recombinant vectors.
• Co-transfection of these vectors into COS-7 cells.
• Assessment of NF-kappaB silencing using Western blot and inverted fluorescence microscopy.

Main Results:

• The pSilencer 1.0-U6-siRNA-NF-kappaB vector demonstrated effective and specific silencing of NF-kappaB protein.
• A dose-dependent reduction in NF-kappaB protein levels was observed with increasing vector concentration.
• Silencing was confirmed through Western blot analysis and inverted fluorescence microscopy.

Conclusions:

• Successful construction of an NF-kappaB siRNA expression vector.
• The developed vector provides a reliable tool for specific NF-kappaB gene silencing.